One of the most active areas in regenerative medicine research today centers on exosomes and mesenchymal stem cells. Our clinical team follows this literature closely. This page is a curated entry point into the research, organized by clinical application.

Why This Research Matters

Exosomes are small extracellular vesicles that carry signaling molecules — proteins, lipids, and small RNAs — between cells. Mesenchymal stem cells (MSCs) are a type of adult stem cell that can be sourced from several tissues and have been studied for their ability to support regeneration and modulate inflammation. The two are deeply connected: a substantial portion of what MSCs do appears to happen through the exosomes they release. Understanding both is increasingly important to understanding what regenerative therapies can and can’t do.

Areas of Active Research

• Tissue repair and wound healing: MSC-derived exosomes for skin regeneration, scar reduction, and chronic wound care.
• Orthopedics: Cartilage repair in osteoarthritis, fracture healing, bone regeneration, and tendon recovery.
• Neurology and neurodegeneration: Stem cell therapy for neuropathic pain, traumatic brain injury, stroke recovery, and neurocognitive disorders.
• Cardiovascular and pulmonary: Cardiac regeneration, pulmonary arterial hypertension, and COPD-related research.
• Immune modulation: Roles of exosomes and MSCs in inflammatory disease, autoimmunity, and infection response.
• Oncology: Exosomes in the tumor microenvironment — both as a research target and a potential therapeutic delivery system.
• Aging: Cellular senescence, age-related decline, and the role of secreted vesicles in maintenance of tissue function.

How We Use This Research

Peer-reviewed research informs which therapies we offer, how we discuss expected outcomes, and where we set expectations. Not every promising study translates to clinical care. Part of our role is filtering early signal from established practice — and being honest with patients about which is which.

What’s Established vs. What’s Emerging

• Well-established: PRP for specific orthopedic indications. Use of MSCs in approved, regulated settings for certain conditions.
• Active investigation: Exosome therapy, MSC-derived exosomes for tissue-specific applications, peptide-based regenerative protocols.
• Early-stage: Many neurological and longevity-focused applications, though the research base is growing quickly.

Want to Go Deeper?

The full library of source papers is maintained internally. If you’re a patient with a specific condition and want to understand the research relevant to your situation, ask your clinician — they can point you to the most relevant studies and translate the findings into what it means for your care.

Approved by the Chambers Clinic Team — last reviewed May 28, 2026.